Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2578)	7/24/2000 1:08:40 PM
From: pz	Respond to of 5582

Dan, My Aunt was advised by her doctor not to try Zicam Allergy relief, because he didn't know what was in it. She tried it anyway and has had such great success with it, that she doesn't use her other medication now for her allergies. I know very little about this product, but I do know it seems to work for my aunt. Paul

To: DanZ who wrote (2578)	7/24/2000 5:11:03 PM
From: Hank	Respond to of 5582

One conclusion I "jumped" to that still seems to ring true is that GUMM always has been and always will be a NET money LOSER. I think I even went so far as to say that there was ZERO percent chance that GUMM would turn a profit for this year and, so far, they're doing an excellent job of proving me correct. I sure seem to be a hell of a lot closer to the truth with these "assumptions" than your well calculated expert opinion that GUMM would be trading in the $60-$100 range by the end of 2000. What's your target these days? $20? Mine's $5. Let's see who's correct- again. Of course, I'm just making an ignorant guess.